Dermapharm Holding SE
OTC: DMPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hans-Georg Feldmeier
- Employees
- 3,610
- Headquarters
- Grünwald, Germany
- IPO year
- 2022
- Market cap
- $2.6B
- Website
- https://www.dermapharm.de
Loading DMPHF…
Loading profile data…Frequently asked questions about DMPHF
What does Dermapharm Holding SE (DMPHF) do?
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Imports, and Herbal Extracts. The company's comprehensive activities...
Where does DMPHF trade?
Dermapharm Holding SE (DMPHF) trades on the Other OTC.
What sector is DMPHF in?
Dermapharm Holding SE (DMPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Dermapharm Holding SE?
Hans-Georg Feldmeier is the chief executive officer of Dermapharm Holding SE (DMPHF).
Where is Dermapharm Holding SE headquartered?
Dermapharm Holding SE is headquartered in Germany.
Does DMPHF pay a dividend?
Yes — Dermapharm Holding SE (DMPHF) paid a trailing twelve-month dividend of USD 1.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did DMPHF go public?
Dermapharm Holding SE (DMPHF) completed its initial public offering in 2022.